ArticleACS omega2026
Rapid Detection of Amyloid β1-42 via PAMAM G4 Supported Molecularly Imprinted Sensor.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this research, a novel sensor system was prepared for the rapid and selective determination of Amyloid β1-42 (Aβ1-42), a key biomarker in the early recognition of Alzheimer's disease. A screen-printed gold electrode (AuE) was used as the base for a self-assembled monolayer (SAM)-based molecularly imprinted polymer (MIP). The electrode was modified by sequential incubation in 100 mM cysteamine, 5% glutaraldehyde, and PAMAM G4 dendrimer. Electropolymerization was performed using pyrrole-3-carboxylic acid and Aβ1-42. Desorption was achieved using 500 mM HCl to remove the template molecule, generating specific recognition sites. The sensor's performance was determined by electrochemical impedance spectroscopy (EIS) and cyclic voltammetry (CV), with additional surface characterization via SEM, XPS, and FT-IR. The nonimprinted polymer (NIP) showed no response to Aβ1-42, confirming the selectivity of the MIP. Selectivity tests using Tau protein showed minimal interference. The quantification limit (LOQ) and the limit of detection (LOD) were found to be 0.42 and 0.14 ng/mL, respectively. In diagnostic applications, the proposed sensor shows promise as a quick, sensitive, and selective way to detect Aβ1-42.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.